KannaLife Sciences, a subsidiary of Neuropathix, Inc., is a biopharmaceutical company dedicated to developing innovative therapeutics. Focused on addressing inflammation and treating neuropathic pain, the company leverages a patented pipeline of monotherapeutic molecules targeting unmet medical needs within the biotechnology and life sciences sectors.
Specialties
Neuropathic Pain Therapeutics
Innovative CBD-like Molecules
Targeting Inflammation
Antioxidant and Neuroprotectant Agents
Patented Drug Candidates
Products & Services
Cannabinoid Therapeutics
Monotherapeutic Molecules
Neuropathic Pain Treatments
Oxidative Stress Solutions
Chronic Pain Management
Contact Information
No contact information available
Competitors & Similar Companies(9)
Innovative Med Concepts
Cara Therapeutics
Connecticut, • United States
Axovant Gene Therapies
Basel-City, • Switzerland
Neurocrine Biosciences
California, • United States
Horizon Therapeutics
Sorrento Therapeutics
California, • United States
Zynerba Pharmaceuticals
Pennsylvania, • United States
Galera Therapeutics
Pennsylvania, • United States
Aurinia Pharmaceuticals
British Columbia, • Canada
News & Media
Search Terms:
kannalifekannalife sciences
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about KannaLife Sciences
Where is KannaLife Sciences located?
The headquarter of KannaLife Sciences is located in Doylestown, Pennsylvania, United States
What is the official website of KannaLife Sciences?
Competitors of KannaLife Sciences are Innovative Med Concepts, Cara Therapeutics, Axovant Gene Therapies, Neurocrine Biosciences, Horizon Therapeutics, Sorrento Therapeutics, Zynerba Pharmaceuticals, Galera Therapeutics, Aurinia Pharmaceuticals.
What does KannaLife Sciences do?
KannaLife Sciences, a subsidiary of Neuropathix, Inc., is a biopharmaceutical company dedicated to developing innovative therapeutics. Focused on addressing inflammation and treating neuropathic pain, the company leverages a patented pipeline of monotherapeutic molecules targeting unmet medical needs within the biotechnology and life sciences sectors.
What are the social media links of KannaLife Sciences?